Industry Research Reports

Home > Reports > Service & Software > Global Mammalian CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Mammalian CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Service & Software

Published Date: 2026-03-31

Pages: 105 Pages

Report ld: 6410952

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Mammalian CDMO Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.

In 2025, the North America Mammalian CDMO Service market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.

The global key players of Mammalian CDMO Service include Cytovance Biologics, 3P Bio, AGC Biologics, KBI Biopharma, GTP Bioways, Tanvex CDMO, Samsung Biologics, WuXi Biologics, PlantForm Corporation, Gedeon Richter, among others. In 2025, the top five players accounted for approximately % of global market revenue.

In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.

The global Mammalian CDMO Service market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.

MARKET SEGMENTATION

By Company

Cytovance Biologics
3P Bio
AGC Biologics
KBI Biopharma
GTP Bioways
Tanvex CDMO
Samsung Biologics
WuXi Biologics
PlantForm Corporation
Gedeon Richter
Lonza
Novartis
Rentschler Biopharma SE
Northway Biotech
Boehringer Ingelheim
Cambrex
FUJIFILM Diosynth Biotechnologies
GBI
Scorpius BioManufacturing

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Cell Line Development
Genomic Analysis
Process Development
Analytical Services
Formulation Development
Manufacturing
Others

Segment by Application

Contract Research Organizations (CROs)
Pharmaceutical
Biotechnology Companies
Government Agencies
Others

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Mammalian CDMO Service value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032

1.2.2 Cell Line Development

1.2.3 Genomic Analysis

1.2.4 Process Development

1.2.5 Analytical Services

1.2.6 Formulation Development

1.2.7 Manufacturing

1.2.8 Others

1.3 Market by Application

1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032

1.3.2 Contract Research Organizations (CROs)

1.3.3 Pharmaceutical

1.3.4 Biotechnology Companies

1.3.5 Government Agencies

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Mammalian CDMO Service Market Perspective (2021-2032)

2.2 Global Market Size by Region: 2021 vs 2025 vs 2032

2.3 Global Mammalian CDMO Service Market Share by Revenue, by Region (2021-2026)

2.4 Global Mammalian CDMO Service Revenue Forecast by Region (2027-2032)

2.5 Major Regions and Emerging Markets Analysis

2.5.1 North America Mammalian CDMO Service Market Size and Prospective (2021-2032)

2.5.2 Europe Mammalian CDMO Service Market Size and Prospective (2021-2032)

2.5.3 Asia-Pacific Mammalian CDMO Service Market Size and Prospective (2021-2032)

2.5.4 Latin America Mammalian CDMO Service Market Size and Prospective (2021-2032)

2.5.5 Middle East & Africa Mammalian CDMO Service Market Size and Prospective (2021-2032)

3 Breakdown Data by Type

3.1 Global Mammalian CDMO Service Historical Market Size by Type (2021-2026)

3.2 Global Mammalian CDMO Service Forecasted Market Size by Type (2027-2032)

3.3 Representative Players for Different Types of Mammalian CDMO Service

4 Breakdown Data by Application

4.1 Global Mammalian CDMO Service Historical Market Size by Application (2021-2026)

4.2 Global Mammalian CDMO Service Forecasted Market Size by Application (2027-2032)

4.3 New Sources of Growth in Mammalian CDMO Service Applications

5 Competitive Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Mammalian CDMO Service Players by Revenue (2021-2026)

5.1.2 Global Mammalian CDMO Service Market Share by Revenue, by Players (2021-2026)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Mammalian CDMO Service Revenue

5.4 Global Mammalian CDMO Service Market Concentration Analysis

5.4.1 Global Mammalian CDMO Service Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Mammalian CDMO Service Revenue in 2025

5.5 Global Key Players of Mammalian CDMO Service Head Offices and Areas Served

5.6 Global Key Players of Mammalian CDMO Service, Product and Application

5.7 Global Key Players of Mammalian CDMO Service, Date of Entry into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Mammalian CDMO Service Revenue by Company (2021-2026)

6.1.2 North America Market Size by Type

6.1.2.1 North America Mammalian CDMO Service Market Size by Type (2021-2026)

6.1.2.2 North America Mammalian CDMO Service Market Share by Type (2021-2026)

6.1.3 North America Market Size by Application

6.1.3.1 North America Mammalian CDMO Service Market Size by Application (2021-2026)

6.1.3.2 North America Mammalian CDMO Service Market Share by Application (2021-2026)

6.1.4 North America Mammalian CDMO Service Major Customers

6.1.5 North America Market Trends and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Mammalian CDMO Service Revenue by Company (2021-2026)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Mammalian CDMO Service Market Size by Type (2021-2026)

6.2.2.2 Europe Mammalian CDMO Service Market Share by Type (2021-2026)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Mammalian CDMO Service Market Size by Application (2021-2026)

6.2.3.2 Europe Mammalian CDMO Service Market Share by Application (2021-2026)

6.2.4 Europe Mammalian CDMO Service Major Customers

6.2.5 Europe Market Trends and Opportunities

6.3 Asia-Pacific Market: Players, Segments, Downstream and Major Customers

6.3.1 Asia-Pacific Mammalian CDMO Service Revenue by Company (2021-2026)

6.3.2 Asia-Pacific Market Size by Type

6.3.2.1 Asia-Pacific Mammalian CDMO Service Market Size by Type (2021-2026)

6.3.2.2 Asia-Pacific Mammalian CDMO Service Market Share by Type (2021-2026)

6.3.3 Asia-Pacific Market Size by Application

6.3.3.1 Asia-Pacific Mammalian CDMO Service Market Size by Application (2021-2026)

6.3.3.2 Asia-Pacific Mammalian CDMO Service Market Share by Application (2021-2026)

6.3.4 Asia-Pacific Mammalian CDMO Service Major Customers

6.3.5 Asia-Pacific Market Trends and Opportunities

6.4 Latin America Market: Players, Segments, Downstream and Major Customers

6.4.1 Latin America Mammalian CDMO Service Revenue by Company (2021-2026)

6.4.2 Latin America Market Size by Type

6.4.2.1 Latin America Mammalian CDMO Service Market Size by Type (2021-2026)

6.4.2.2 Latin America Mammalian CDMO Service Market Share by Type (2021-2026)

6.4.3 Latin America Market Size by Application

6.4.3.1 Latin America Mammalian CDMO Service Market Size by Application (2021-2026)

6.4.3.2 Latin America Mammalian CDMO Service Market Share by Application (2021-2026)

6.4.4 Latin America Mammalian CDMO Service Major Customers

6.4.5 Latin America Market Trends and Opportunities

6.5 Middle East & Africa Market: Players, Segments, Downstream and Major Customers

6.5.1 Middle East & Africa Mammalian CDMO Service Revenue by Company (2021-2026)

6.5.2 Middle East & Africa Market Size by Type

6.5.2.1 Middle East & Africa Mammalian CDMO Service Market Size by Type (2021-2026)

6.5.2.2 Middle East & Africa Mammalian CDMO Service Market Share by Type (2021-2026)

6.5.3 Middle East & Africa Market Size by Application

6.5.3.1 Middle East & Africa Mammalian CDMO Service Market Size by Application (2021-2026)

6.5.3.2 Middle East & Africa Mammalian CDMO Service Market Share by Application (2021-2026)

6.5.4 Middle East & Africa Mammalian CDMO Service Major Customers

6.5.5 Middle East & Africa Market Trends and Opportunities

7 Key Player Profiles

7.1 Cytovance Biologics

7.1.1 Cytovance Biologics Company Details

7.1.2 Cytovance Biologics Business Overview

7.1.3 Cytovance Biologics Mammalian CDMO Service Introduction

7.1.4 Cytovance Biologics Revenue in Mammalian CDMO Service Business (2021-2026)

7.1.5 Cytovance Biologics Recent Development

7.2 3P Bio

7.2.1 3P Bio Company Details

7.2.2 3P Bio Business Overview

7.2.3 3P Bio Mammalian CDMO Service Introduction

7.2.4 3P Bio Revenue in Mammalian CDMO Service Business (2021-2026)

7.2.5 3P Bio Recent Development

7.3 AGC Biologics

7.3.1 AGC Biologics Company Details

7.3.2 AGC Biologics Business Overview

7.3.3 AGC Biologics Mammalian CDMO Service Introduction

7.3.4 AGC Biologics Revenue in Mammalian CDMO Service Business (2021-2026)

7.3.5 AGC Biologics Recent Development

7.4 KBI Biopharma

7.4.1 KBI Biopharma Company Details

7.4.2 KBI Biopharma Business Overview

7.4.3 KBI Biopharma Mammalian CDMO Service Introduction

7.4.4 KBI Biopharma Revenue in Mammalian CDMO Service Business (2021-2026)

7.4.5 KBI Biopharma Recent Development

7.5 GTP Bioways

7.5.1 GTP Bioways Company Details

7.5.2 GTP Bioways Business Overview

7.5.3 GTP Bioways Mammalian CDMO Service Introduction

7.5.4 GTP Bioways Revenue in Mammalian CDMO Service Business (2021-2026)

7.5.5 GTP Bioways Recent Development

7.6 Tanvex CDMO

7.6.1 Tanvex CDMO Company Details

7.6.2 Tanvex CDMO Business Overview

7.6.3 Tanvex CDMO Mammalian CDMO Service Introduction

7.6.4 Tanvex CDMO Revenue in Mammalian CDMO Service Business (2021-2026)

7.6.5 Tanvex CDMO Recent Development

7.7 Samsung Biologics

7.7.1 Samsung Biologics Company Details

7.7.2 Samsung Biologics Business Overview

7.7.3 Samsung Biologics Mammalian CDMO Service Introduction

7.7.4 Samsung Biologics Revenue in Mammalian CDMO Service Business (2021-2026)

7.7.5 Samsung Biologics Recent Development

7.8 WuXi Biologics

7.8.1 WuXi Biologics Company Details

7.8.2 WuXi Biologics Business Overview

7.8.3 WuXi Biologics Mammalian CDMO Service Introduction

7.8.4 WuXi Biologics Revenue in Mammalian CDMO Service Business (2021-2026)

7.8.5 WuXi Biologics Recent Development

7.9 PlantForm Corporation

7.9.1 PlantForm Corporation Company Details

7.9.2 PlantForm Corporation Business Overview

7.9.3 PlantForm Corporation Mammalian CDMO Service Introduction

7.9.4 PlantForm Corporation Revenue in Mammalian CDMO Service Business (2021-2026)

7.9.5 PlantForm Corporation Recent Development

7.10 Gedeon Richter

7.10.1 Gedeon Richter Company Details

7.10.2 Gedeon Richter Business Overview

7.10.3 Gedeon Richter Mammalian CDMO Service Introduction

7.10.4 Gedeon Richter Revenue in Mammalian CDMO Service Business (2021-2026)

7.10.5 Gedeon Richter Recent Development

7.11 Lonza

7.11.1 Lonza Company Details

7.11.2 Lonza Business Overview

7.11.3 Lonza Mammalian CDMO Service Introduction

7.11.4 Lonza Revenue in Mammalian CDMO Service Business (2021-2026)

7.11.5 Lonza Recent Development

7.12 Novartis

7.12.1 Novartis Company Details

7.12.2 Novartis Business Overview

7.12.3 Novartis Mammalian CDMO Service Introduction

7.12.4 Novartis Revenue in Mammalian CDMO Service Business (2021-2026)

7.12.5 Novartis Recent Development

7.13 Rentschler Biopharma SE

7.13.1 Rentschler Biopharma SE Company Details

7.13.2 Rentschler Biopharma SE Business Overview

7.13.3 Rentschler Biopharma SE Mammalian CDMO Service Introduction

7.13.4 Rentschler Biopharma SE Revenue in Mammalian CDMO Service Business (2021-2026)

7.13.5 Rentschler Biopharma SE Recent Development

7.14 Northway Biotech

7.14.1 Northway Biotech Company Details

7.14.2 Northway Biotech Business Overview

7.14.3 Northway Biotech Mammalian CDMO Service Introduction

7.14.4 Northway Biotech Revenue in Mammalian CDMO Service Business (2021-2026)

7.14.5 Northway Biotech Recent Development

7.15 Boehringer Ingelheim

7.15.1 Boehringer Ingelheim Company Details

7.15.2 Boehringer Ingelheim Business Overview

7.15.3 Boehringer Ingelheim Mammalian CDMO Service Introduction

7.15.4 Boehringer Ingelheim Revenue in Mammalian CDMO Service Business (2021-2026)

7.15.5 Boehringer Ingelheim Recent Development

7.16 Cambrex

7.16.1 Cambrex Company Details

7.16.2 Cambrex Business Overview

7.16.3 Cambrex Mammalian CDMO Service Introduction

7.16.4 Cambrex Revenue in Mammalian CDMO Service Business (2021-2026)

7.16.5 Cambrex Recent Development

7.17 FUJIFILM Diosynth Biotechnologies

7.17.1 FUJIFILM Diosynth Biotechnologies Company Details

7.17.2 FUJIFILM Diosynth Biotechnologies Business Overview

7.17.3 FUJIFILM Diosynth Biotechnologies Mammalian CDMO Service Introduction

7.17.4 FUJIFILM Diosynth Biotechnologies Revenue in Mammalian CDMO Service Business (2021-2026)

7.17.5 FUJIFILM Diosynth Biotechnologies Recent Development

7.18 GBI

7.18.1 GBI Company Details

7.18.2 GBI Business Overview

7.18.3 GBI Mammalian CDMO Service Introduction

7.18.4 GBI Revenue in Mammalian CDMO Service Business (2021-2026)

7.18.5 GBI Recent Development

7.19 Scorpius BioManufacturing

7.19.1 Scorpius BioManufacturing Company Details

7.19.2 Scorpius BioManufacturing Business Overview

7.19.3 Scorpius BioManufacturing Mammalian CDMO Service Introduction

7.19.4 Scorpius BioManufacturing Revenue in Mammalian CDMO Service Business (2021-2026)

7.19.5 Scorpius BioManufacturing Recent Development

8 Mammalian CDMO Service Market Dynamics

8.1 Mammalian CDMO Service Industry Trends

8.2 Mammalian CDMO Service Market Drivers

8.3 Mammalian CDMO Service Market Challenges

8.4 Mammalian CDMO Service Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Mammalian CDMO Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Global Mammalian CDMO Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 3. Global Market Mammalian CDMO Service Market Size (US$ Million) by Region:2021 vs 2025 vs 2032

Table 4. Global Mammalian CDMO Service Revenue (US$ Million) Market Share by Region (2021-2026)

Table 5. Global Mammalian CDMO Service Revenue Share by Region (2021-2026)

Table 6. Global Mammalian CDMO Service Revenue (US$ Million) Forecast by Region (2027-2032)

Table 7. Global Mammalian CDMO Service Revenue Share Forecast by Region (2027-2032)

Table 8. Global Mammalian CDMO Service Market Size by Type (2021-2026) & (US$ Million)

Table 9. Global Mammalian CDMO Service Market Share by Revenue, by Type (2021-2026)

Table 10. Global Mammalian CDMO Service Forecasted Market Size by Type (2027-2032) & (US$ Million)

Table 11. Global Mammalian CDMO Service Market Share by Revenue, by Type (2027-2032)

Table 12. Representative Players of Each Type

Table 13. Global Mammalian CDMO Service Market Size by Application (2021-2026) & (US$ Million)

Table 14. Global Mammalian CDMO Service Market Share by Revenue, by Application (2021-2026)

Table 15. Global Mammalian CDMO Service Forecasted Market Size by Application (2027-2032) & (US$ Million)

Table 16. Global Mammalian CDMO Service Market Share by Revenue, by Application (2027-2032)

Table 17. New Sources of Growth in Mammalian CDMO Service Applications

Table 18. Global Mammalian CDMO Service Revenue by Players (2021-2026) & (US$ Million)

Table 19. Global Mammalian CDMO Service Market Share by Players (2021-2026)

Table 20. Global Top Mammalian CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mammalian CDMO Service as of 2025)

Table 21. Ranking of Global Top Mammalian CDMO Service Companies by Revenue (US$ Million) in 2025

Table 22. Global 5 Largest Players Market Share by Mammalian CDMO Service Revenue (CR5 and HHI) & (2021-2026)

Table 23. Global Key Players of Mammalian CDMO Service, Headquarters and Area Served

Table 24. Global Key Players of Mammalian CDMO Service, Product and Application

Table 25. Global Key Players of Mammalian CDMO Service, Date of Entry into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Mammalian CDMO Service Revenue by Company (2021-2026) & (US$ Million)

Table 28. North America Mammalian CDMO Service Market Share by Revenue, by Company (2021-2026)

Table 29. North America Mammalian CDMO Service Market Size by Type (2021-2026) & (US$ Million)

Table 30. North America Mammalian CDMO Service Market Size by Application (2021-2026) & (US$ Million)

Table 31. Europe Mammalian CDMO Service Revenue by Company (2021-2026) & (US$ Million)

Table 32. Europe Mammalian CDMO Service Market Share by Revenue, by Company (2021-2026)

Table 33. Europe Mammalian CDMO Service Market Size by Type (2021-2026) & (US$ Million)

Table 34. Europe Mammalian CDMO Service Market Size by Application (2021-2026) & (US$ Million)

Table 35. Asia-Pacific Mammalian CDMO Service Revenue by Company (2021-2026) & (US$ Million)

Table 36. Asia-Pacific Mammalian CDMO Service Market Share by Revenue, by Company (2021-2026)

Table 37. Asia-Pacific Mammalian CDMO Service Market Size by Type (2021-2026) & (US$ Million)

Table 38. Asia-Pacific Mammalian CDMO Service Market Size by Application (2021-2026) & (US$ Million)

Table 39. Latin America Mammalian CDMO Service Revenue by Company (2021-2026) & (US$ Million)

Table 40. Latin America Mammalian CDMO Service Market Share by Revenue, by Company (2021-2026)

Table 41. Latin America Mammalian CDMO Service Market Size by Type (2021-2026) & (US$ Million)

Table 42. Latin America Mammalian CDMO Service Market Size by Application (2021-2026) & (US$ Million)

Table 43. Middle East & Africa Mammalian CDMO Service Revenue by Company (2021-2026) & (US$ Million)

Table 44. Middle East & Africa Mammalian CDMO Service Market Share by Revenue, by Company (2021-2026)

Table 45. Middle East & Africa Mammalian CDMO Service Market Size by Type (2021-2026) & (US$ Million)

Table 46. Middle East & Africa Mammalian CDMO Service Market Size by Application (2021-2026) & (US$ Million)

Table 47. Cytovance Biologics Company Details

Table 48. Cytovance Biologics Business Overview

Table 49. Cytovance Biologics Mammalian CDMO Service Product

Table 50. Cytovance Biologics Revenue in Mammalian CDMO Service Business (2021-2026) & (US$ Million)

Table 51. Cytovance Biologics Recent Development

Table 52. 3P Bio Company Details

Table 53. 3P Bio Business Overview

Table 54. 3P Bio Mammalian CDMO Service Product

Table 55. 3P Bio Revenue in Mammalian CDMO Service Business (2021-2026) & (US$ Million)

Table 56. 3P Bio Recent Development

Table 57. AGC Biologics Company Details

Table 58. AGC Biologics Business Overview

Table 59. AGC Biologics Mammalian CDMO Service Product

Table 60. AGC Biologics Revenue in Mammalian CDMO Service Business (2021-2026) & (US$ Million)

Table 61. AGC Biologics Recent Development

Table 62. KBI Biopharma Company Details

Table 63. KBI Biopharma Business Overview

Table 64. KBI Biopharma Mammalian CDMO Service Product

Table 65. KBI Biopharma Revenue in Mammalian CDMO Service Business (2021-2026) & (US$ Million)

Table 66. KBI Biopharma Recent Development

Table 67. GTP Bioways Company Details

Table 68. GTP Bioways Business Overview

Table 69. GTP Bioways Mammalian CDMO Service Product

Table 70. GTP Bioways Revenue in Mammalian CDMO Service Business (2021-2026) & (US$ Million)

Table 71. GTP Bioways Recent Development

Table 72. Tanvex CDMO Company Details

Table 73. Tanvex CDMO Business Overview

Table 74. Tanvex CDMO Mammalian CDMO Service Product

Table 75. Tanvex CDMO Revenue in Mammalian CDMO Service Business (2021-2026) & (US$ Million)

Table 76. Tanvex CDMO Recent Development

Table 77. Samsung Biologics Company Details

Table 78. Samsung Biologics Business Overview

Table 79. Samsung Biologics Mammalian CDMO Service Product

Table 80. Samsung Biologics Revenue in Mammalian CDMO Service Business (2021-2026) & (US$ Million)

Table 81. Samsung Biologics Recent Development

Table 82. WuXi Biologics Company Details

Table 83. WuXi Biologics Business Overview

Table 84. WuXi Biologics Mammalian CDMO Service Product

Table 85. WuXi Biologics Revenue in Mammalian CDMO Service Business (2021-2026) & (US$ Million)

Table 86. WuXi Biologics Recent Development

Table 87. PlantForm Corporation Company Details

Table 88. PlantForm Corporation Business Overview

Table 89. PlantForm Corporation Mammalian CDMO Service Product

Table 90. PlantForm Corporation Revenue in Mammalian CDMO Service Business (2021-2026) & (US$ Million)

Table 91. PlantForm Corporation Recent Development

Table 92. Gedeon Richter Company Details

Table 93. Gedeon Richter Business Overview

Table 94. Gedeon Richter Mammalian CDMO Service Product

Table 95. Gedeon Richter Revenue in Mammalian CDMO Service Business (2021-2026) & (US$ Million)

Table 96. Gedeon Richter Recent Development

Table 97. Lonza Company Details

Table 98. Lonza Business Overview

Table 99. Lonza Mammalian CDMO Service Product

Table 100. Lonza Revenue in Mammalian CDMO Service Business (2021-2026) & (US$ Million)

Table 101. Lonza Recent Development

Table 102. Novartis Company Details

Table 103. Novartis Business Overview

Table 104. Novartis Mammalian CDMO Service Product

Table 105. Novartis Revenue in Mammalian CDMO Service Business (2021-2026) & (US$ Million)

Table 106. Novartis Recent Development

Table 107. Rentschler Biopharma SE Company Details

Table 108. Rentschler Biopharma SE Business Overview

Table 109. Rentschler Biopharma SE Mammalian CDMO Service Product

Table 110. Rentschler Biopharma SE Revenue in Mammalian CDMO Service Business (2021-2026) & (US$ Million)

Table 111. Rentschler Biopharma SE Recent Development

Table 112. Northway Biotech Company Details

Table 113. Northway Biotech Business Overview

Table 114. Northway Biotech Mammalian CDMO Service Product

Table 115. Northway Biotech Revenue in Mammalian CDMO Service Business (2021-2026) & (US$ Million)

Table 116. Northway Biotech Recent Development

Table 117. Boehringer Ingelheim Company Details

Table 118. Boehringer Ingelheim Business Overview

Table 119. Boehringer Ingelheim Mammalian CDMO Service Product

Table 120. Boehringer Ingelheim Revenue in Mammalian CDMO Service Business (2021-2026) & (US$ Million)

Table 121. Boehringer Ingelheim Recent Development

Table 122. Cambrex Company Details

Table 123. Cambrex Business Overview

Table 124. Cambrex Mammalian CDMO Service Product

Table 125. Cambrex Revenue in Mammalian CDMO Service Business (2021-2026) & (US$ Million)

Table 126. Cambrex Recent Development

Table 127. FUJIFILM Diosynth Biotechnologies Company Details

Table 128. FUJIFILM Diosynth Biotechnologies Business Overview

Table 129. FUJIFILM Diosynth Biotechnologies Mammalian CDMO Service Product

Table 130. FUJIFILM Diosynth Biotechnologies Revenue in Mammalian CDMO Service Business (2021-2026) & (US$ Million)

Table 131. FUJIFILM Diosynth Biotechnologies Recent Development

Table 132. GBI Company Details

Table 133. GBI Business Overview

Table 134. GBI Mammalian CDMO Service Product

Table 135. GBI Revenue in Mammalian CDMO Service Business (2021-2026) & (US$ Million)

Table 136. GBI Recent Development

Table 137. Scorpius BioManufacturing Company Details

Table 138. Scorpius BioManufacturing Business Overview

Table 139. Scorpius BioManufacturing Mammalian CDMO Service Product

Table 140. Scorpius BioManufacturing Revenue in Mammalian CDMO Service Business (2021-2026) & (US$ Million)

Table 141. Scorpius BioManufacturing Recent Development

Table 142. Mammalian CDMO Service Market Trends

Table 143. Mammalian CDMO Service Market Drivers

Table 144. Mammalian CDMO Service Market Challenges

Table 145. Mammalian CDMO Service Market Restraints

Table 146. Research Programs/Design for This Report

Table 147. Key Data Information from Secondary Sources

Table 148. Key Data Information from Primary Sources

List of Figures

Figure 1. Mammalian CDMO Service Product Picture

Figure 2. Global Mammalian CDMO Service Market Share by Type: 2025 vs 2032

Figure 3. Cell Line Development Features

Figure 4. Genomic Analysis Features

Figure 5. Process Development Features

Figure 6. Analytical Services Features

Figure 7. Formulation Development Features

Figure 8. Manufacturing Features

Figure 9. Others Features

Figure 10. Global Mammalian CDMO Service Market Share by Application: 2025 vs 2032

Figure 11. Contract Research Organizations (CROs)

Figure 12. Pharmaceutical

Figure 13. Biotechnology Companies

Figure 14. Government Agencies

Figure 15. Others

Figure 16. Mammalian CDMO Service Report Years Considered

Figure 17. Global Mammalian CDMO Service Market Size (US$ Million), Year-over-Year: 2021-2032

Figure 18. Global Mammalian CDMO Service Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 19. Global Mammalian CDMO Service Market Share by Revenue, by Region: 2021 vs 2025

Figure 20. North America Mammalian CDMO Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 21. Europe Mammalian CDMO Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 22. Asia-Pacific Mammalian CDMO Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 23. Latin America Mammalian CDMO Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 24. Middle East & Africa Mammalian CDMO Service Revenue (US$ Million) Growth Rate (2021-2032)

Figure 25. Global Mammalian CDMO Service Market Share by Players in 2025

Figure 26. Global Top Mammalian CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mammalian CDMO Service as of 2025)

Figure 27. The Top 10 and 5 Players Market Share by Mammalian CDMO Service Revenue in 2025

Figure 28. North America Mammalian CDMO Service Market Share by Type (2021-2026)

Figure 29. North America Mammalian CDMO Service Market Share by Application (2021-2026)

Figure 30. Europe Mammalian CDMO Service Market Share by Type (2021-2026)

Figure 31. Europe Mammalian CDMO Service Market Share by Application (2021-2026)

Figure 32. Asia-Pacific Mammalian CDMO Service Market Share by Type (2021-2026)

Figure 33. Asia-Pacific Mammalian CDMO Service Market Share by Application (2021-2026)

Figure 34. Latin America Mammalian CDMO Service Market Share by Type (2021-2026)

Figure 35. Latin America Mammalian CDMO Service Market Share by Application (2021-2026)

Figure 36. Middle East & Africa Mammalian CDMO Service Market Share by Type (2021-2026)

Figure 37. Middle East & Africa Mammalian CDMO Service Market Share by Application (2021-2026)

Figure 38. Cytovance Biologics Revenue Growth Rate in Mammalian CDMO Service Business (2021-2026)

Figure 39. 3P Bio Revenue Growth Rate in Mammalian CDMO Service Business (2021-2026)

Figure 40. AGC Biologics Revenue Growth Rate in Mammalian CDMO Service Business (2021-2026)

Figure 41. KBI Biopharma Revenue Growth Rate in Mammalian CDMO Service Business (2021-2026)

Figure 42. GTP Bioways Revenue Growth Rate in Mammalian CDMO Service Business (2021-2026)

Figure 43. Tanvex CDMO Revenue Growth Rate in Mammalian CDMO Service Business (2021-2026)

Figure 44. Samsung Biologics Revenue Growth Rate in Mammalian CDMO Service Business (2021-2026)

Figure 45. WuXi Biologics Revenue Growth Rate in Mammalian CDMO Service Business (2021-2026)

Figure 46. PlantForm Corporation Revenue Growth Rate in Mammalian CDMO Service Business (2021-2026)

Figure 47. Gedeon Richter Revenue Growth Rate in Mammalian CDMO Service Business (2021-2026)

Figure 48. Lonza Revenue Growth Rate in Mammalian CDMO Service Business (2021-2026)

Figure 49. Novartis Revenue Growth Rate in Mammalian CDMO Service Business (2021-2026)

Figure 50. Rentschler Biopharma SE Revenue Growth Rate in Mammalian CDMO Service Business (2021-2026)

Figure 51. Northway Biotech Revenue Growth Rate in Mammalian CDMO Service Business (2021-2026)

Figure 52. Boehringer Ingelheim Revenue Growth Rate in Mammalian CDMO Service Business (2021-2026)

Figure 53. Cambrex Revenue Growth Rate in Mammalian CDMO Service Business (2021-2026)

Figure 54. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Mammalian CDMO Service Business (2021-2026)

Figure 55. GBI Revenue Growth Rate in Mammalian CDMO Service Business (2021-2026)

Figure 56. Scorpius BioManufacturing Revenue Growth Rate in Mammalian CDMO Service Business (2021-2026)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Mammalian CDMO Service market? zhanKai

The top companies in the global Mammalian CDMO Service market are Cytovance Biologics、3P Bio、AGC Biologics.

Related Reports

Global Mammalian CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Mammalian CDMO Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-31
Pages: 148
USD 4900.00
(Single User License)
Mammalian CDMO Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 133
USD 3950.00
(Single User License)
Global Mammalian CDMO Service Market Research Report 2026
The global Mammalian CDMO Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-16
Pages: 122
USD 2900.00
(Single User License)
Global Mammalian CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Mammalian CDMO Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 110
USD 4250.00
(Single User License)
Global Mammalian CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Mammalian CDMO Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 158
USD 4900.00
(Single User License)
Mammalian CDMO Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 124
USD 3950.00
(Single User License)
Global Mammalian CDMO Service Market Research Report 2025
The global market for Mammalian CDMO Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 97
USD 2900.00
(Single User License)
Global Mammalian CDMO Service Market Insights, Forecast to 2030
The global Mammalian CDMO Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-04-10
Pages: 154
USD 4900.00
(Single User License)
Global and United States Mammalian CDMO Service Market Report & Forecast 2024-2030
The global Mammalian CDMO Service revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-04-10
Pages: 126
USD 4350.00
(Single User License)
Mammalian CDMO Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-04-10
Pages: 124
USD 3950.00
(Single User License)

Global Mammalian CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Mammalian CDMO Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-31
Pages: 148
USD 4900.00 (Single User License)
Mammalian CDMO Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 133
USD 3950.00 (Single User License)
Global Mammalian CDMO Service Market Research Report 2026
The global Mammalian CDMO Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-16
Pages: 122
USD 2900.00 (Single User License)
Global Mammalian CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Mammalian CDMO Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 110
USD 4250.00 (Single User License)
Global Mammalian CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Mammalian CDMO Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 158
USD 4900.00 (Single User License)
Mammalian CDMO Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 124
USD 3950.00 (Single User License)
Global Mammalian CDMO Service Market Research Report 2025
The global market for Mammalian CDMO Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 97
USD 2900.00 (Single User License)
Global Mammalian CDMO Service Market Insights, Forecast to 2030
The global Mammalian CDMO Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-04-10
Pages: 154
USD 4900.00 (Single User License)
Global and United States Mammalian CDMO Service Market Report & Forecast 2024-2030
The global Mammalian CDMO Service revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-04-10
Pages: 126
USD 4350.00 (Single User License)
Mammalian CDMO Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published: 2024-04-10
Pages: 124
USD 3950.00 (Single User License)